To explore whether the addition of plasma CTSD levels to the existing hepatic disease parameters would benefit MetALD/ALD prediction, receiver-operating characteristic curves of AST/ALT ratio and LSM with or without plasma CTSD levels were plotted. The gene discussed is GPT; the disease is liver disorder.